Insider Transactions in Q1 2022 at Bioventus Inc. (BVS)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2022
|
Alessandra Pavesio Fmr. SVP & Chief Science Off. |
SELL
Open market or private sale
|
Direct |
433
-0.36%
|
$4,763
$11.99 P/Share
|
|
Feb 14
2022
|
John Nosenzo Fmr. Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
534
-1.22%
|
$5,874
$11.99 P/Share
|
|
Feb 14
2022
|
Gregory O. Anglum SVP & CFO |
SELL
Open market or private sale
|
Direct |
1,294
-2.3%
|
$14,234
$11.99 P/Share
|
|
Feb 14
2022
|
Anthony D'Adamio SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
1,294
-6.48%
|
$14,234
$11.99 P/Share
|
|
Feb 11
2022
|
Martin P Sutter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+50.0%
|
-
|
|
Feb 11
2022
|
William A Hawkins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,500
+20.68%
|
-
|
|
Feb 11
2022
|
Susan M Stalnecker Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+50.0%
|
-
|
|
Feb 11
2022
|
Philip G. Cowdy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+50.0%
|
-
|
|
Feb 11
2022
|
John Nosenzo Fmr. Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,470
+3.24%
|
-
|
|
Feb 11
2022
|
Gregory O. Anglum SVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,400
+7.25%
|
-
|
|
Feb 11
2022
|
Anthony D'Adamio SVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,400
+18.06%
|
-
|
|
Feb 11
2022
|
Guy P Nohra Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+50.0%
|
-
|
|
Feb 11
2022
|
Guido J Neels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+50.0%
|
-
|
|
Feb 11
2022
|
Alessandra Pavesio Fmr. SVP & Chief Science Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,470
+1.21%
|
-
|
|
Feb 10
2022
|
William A Hawkins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
38,288
+50.0%
|
-
|
|
Feb 10
2022
|
Gregory O. Anglum SVP & CFO |
BUY
Payment of exercise price or tax liability
|
Direct |
19,674
+27.48%
|
$236,088
$12.88 P/Share
|
|
Feb 10
2022
|
Gregory O. Anglum SVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
65,581
+47.81%
|
-
|
|
Feb 10
2022
|
Anthony D'Adamio SVP & General Counsel |
BUY
Payment of exercise price or tax liability
|
Direct |
6,599
+29.77%
|
$79,188
$12.88 P/Share
|
|
Feb 10
2022
|
Anthony D'Adamio SVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
21,165
+48.85%
|
-
|
|
Feb 10
2022
|
John Nosenzo Fmr. Chief Commercial Officer |
BUY
Payment of exercise price or tax liability
|
Direct |
24,205
+36.32%
|
$290,460
$12.88 P/Share
|
|
Feb 10
2022
|
John Nosenzo Fmr. Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
66,139
+49.81%
|
-
|
|
Feb 10
2022
|
Alessandra Pavesio Fmr. SVP & Chief Science Off. |
BUY
Payment of exercise price or tax liability
|
Direct |
73,915
+38.36%
|
$886,980
$12.88 P/Share
|
|
Feb 10
2022
|
Alessandra Pavesio Fmr. SVP & Chief Science Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
191,708
+49.87%
|
-
|